JPMorgan is sticking with Eli Lilly (LLY) as its top biopharma pick for 2025, while also highlighting Gilead Sciences (GILD) ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...

The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

British Prime Minister Keir Starmer, who had met with the family of Eli Sharabi who was freed after 491 days in Hamas captivity, commented on his release on Saturday night. “I shared the relief ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. In an era where financial literacy is increasingly recognized as a crucial ...

Giants Legend Eli Manning, NJ Resident, Not Selected To Football Hall Of Fame Eli Manning, who won two Super Bowls playing quarterback for the New York Giants, will have to wait at least another year ...

Giants Legend Eli Manning, NJ Resident, Not Selected To Football Hall Of Fame Eli Manning, who won two Super Bowls playing quarterback for the New York Giants, will have to wait at least another year ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.